Page results
-
Information about the nutrition and dietetics service at the Royal London Hospital for Integrated Medicine
-
The Neurogenetics Unit offers a fully integrated service encompassing clinical assessment, diagnosis, molecular genetic testing and counselling for neurogenetic conditions.
-
This phlebotomy service is appointment based only (persons who are solely requiring a blood test), including GP patients (Camden & Islington)
-
Diagnostic cytology is a specialist discipline that provides the examination of samples taken by non-invasive or minimally invasive procedures.
-
In partnership with Camden MSK, our department has agreed to provide ultrasound-guided joint and soft tissue injections to patients referred by the Camden community MSK services.
-
UCLH has two mortuaries, one at University College Hospital and one at the National Hospital for Neurology and Neurosurgery (NHNN)
-
This page, written by the Physiotherapy Services at the Royal London Hospital for Integrated Medicine, is intended for patients (or their family or carers) who have been referred to the clinic.
-
This page is designed for patients scheduled to attend our department. It outlines the various tests that may be conducted during your appointment.
-
This page is designed for patients scheduled to attend the Adult diagnostic audiology department. It outlines the various tests that may be conducted during your appointment.
-
Information about sickle cell disorder and pregnancy for UCLH patients.
File results
-
FOI/2023/0007 - Outpatient activity for 2022
-
FOI/2023/0009 - Procedure volumes/ average costs for portable and stable oxygen concentrator devices
-
FOI/2023/0010 - Bardet-biedle Syndrome patient treatment and diagnosis
-
FOI/2023/0013 - Average waiting times for colonoscopy investigations
-
FOI/2023/0014 - Surgery protocols/ standard operating procedures for a feticide
-
FOI/2023/0018 - A&E attendances/ admissions by patients of no fixed abode
-
FOI/2023/0019 - Public access to water refill stations on your premises
-
FOI/2023/0022 - Guidelines staff follow for patients with disabilities and autism
-
FOI/2023/0226 - Treatment with Nivolumab
-
FOI/2023/0225 - Usage of Dabrafenib + Trametinib in cancer treatment